D Agnusdei1, N Iori. Show Affiliations » 1. Skeletal Diseases, Eli Lilly & Co., Eli Lilly Italy, Firenze, Italy.
Abstract
Mesh: See more » AnimalsEstrogen Replacement Therapy/adverse effectsFemaleHot Flashes/chemically inducedHumansOsteoporosis, Postmenopausal/prevention & controlRaloxifene Hydrochloride/adverse effectsRaloxifene Hydrochloride/therapeutic useSelective Estrogen Receptor Modulators/adverse effectsSelective Estrogen Receptor Modulators/therapeutic useTamoxifen/adverse effectsTamoxifen/therapeutic useVenous Thrombosis/chemically induced
Substances: See more » Selective Estrogen Receptor ModulatorsTamoxifenRaloxifene Hydrochloride
Year: 1999 PMID: 10532252 DOI: 10.1007/BF03343622
Source DB: PubMed Journal: J Endocrinol Invest ISSN: 0391-4097 Impact factor: 4.256